[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Page 30344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11392]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: AMRI 
Rensselaer, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: AMRI Rensselaer, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants AMRI Rensselaer, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated November 30, 2015, and 
published in the Federal Register on December 8, 2015, 80 FR 76312, 
AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 
applied to be registered as a manufacturer of certain basic classes of 
controlled substances. No comments or objections were submitted for 
this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of AMRI Rensselaer, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Amphetamine (1100).........................  II
Lisdexamfetamine (1205)....................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)    II
 (8333).
Meperidine (9230)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers.
    In reference to drug codes 7360 (marihuana), and 7370 (THC), the 
company plans to bulk manufacture these drugs as synthetics. No other 
activity for these drug codes are authorized for this registration.

    Dated: April 28, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-11392 Filed 5-13-16; 8:45 am]
 BILLING CODE 4410-09-P